Repurposing of rebamipide as a neuroprotective agent to alleviate letrozole-induced depressive-like behaviors in female rats: Targeting SIRT1/FoxO1/wnt/ β-catenin, and related ferroptosis pathways
Aya Hamdy , Rabab H. Sayed , Mohammed F. El-Yamany , Gouda K. Helal , Mohmed I. Fahmy
{"title":"Repurposing of rebamipide as a neuroprotective agent to alleviate letrozole-induced depressive-like behaviors in female rats: Targeting SIRT1/FoxO1/wnt/ β-catenin, and related ferroptosis pathways","authors":"Aya Hamdy , Rabab H. Sayed , Mohammed F. El-Yamany , Gouda K. Helal , Mohmed I. Fahmy","doi":"10.1016/j.lfs.2025.123941","DOIUrl":null,"url":null,"abstract":"<div><h3>Aims</h3><div>Polycystic ovarian syndrome (PCOS) is a hormonal disorder affecting females worldwide. PCOS is associated with the development of depression, which is exacerbated by oxidative stress, neuro-inflammation, and ferropotosis. Rebamipide (Reba) is a potent antioxidant agent exhibiting cytoprotective effects. Reba notably activates SIRT1, which in turn plays a major role in ameliorating cellular iron deposition, thus preventing ferooptosis-related cell death. This study aimed to elucidate the neuroprotective effects of Reba against letrozole-induced depressive-like behaviour in female rats and further explore the role of SIRT1/FoxO/wnt/β-catenin and related ferroptosis pathways.</div></div><div><h3>Materials and methods</h3><div>Forty female Wistar rats were allocated into four groups: control group, a letrozole-treated group (1 mg/kg/day, p.o.), a Reba-treated group (80 mg/kg/day, p.o.) and a group receiving niacinamide (NAM), a selective SIRT1 blocker (100 mg/kg/day, i.p.) in addition to Reba.</div></div><div><h3>Key findings</h3><div>Reba restored the normal morphological structure of the hippocampi with significant improvement in the rats' behaviors. Reba up-regulated SIRT1, a key regulator of numerous antioxidant and anti-inflammatory cascades, including Nrf2, SOD, and HO-1. The anti-inflammatory activity of SIRT-1 was revealed by the downregulation of NF-κB-p65, TNF-α, and NLRP3 inflammasome, as well as the upregulation of FoxO/wnt/β-catenin signaling. Furthermore, the anti-ferroptosis effects were demonstrated by the inhibition of total iron and ferrous levels as well as the upregulation of Gpx4 and SLC7A11 genes. Pre-treatment with NAM abolished Reba's neuroprotective effects.</div></div><div><h3>Significance</h3><div>Reba has a major neuroprotective role via activating SIRT1 and inhibiting related oxidative, neuroinflammatory, and ferroptosis pathways.</div></div>","PeriodicalId":18122,"journal":{"name":"Life sciences","volume":"380 ","pages":"Article 123941"},"PeriodicalIF":5.1000,"publicationDate":"2025-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Life sciences","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0024320525005764","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Aims
Polycystic ovarian syndrome (PCOS) is a hormonal disorder affecting females worldwide. PCOS is associated with the development of depression, which is exacerbated by oxidative stress, neuro-inflammation, and ferropotosis. Rebamipide (Reba) is a potent antioxidant agent exhibiting cytoprotective effects. Reba notably activates SIRT1, which in turn plays a major role in ameliorating cellular iron deposition, thus preventing ferooptosis-related cell death. This study aimed to elucidate the neuroprotective effects of Reba against letrozole-induced depressive-like behaviour in female rats and further explore the role of SIRT1/FoxO/wnt/β-catenin and related ferroptosis pathways.
Materials and methods
Forty female Wistar rats were allocated into four groups: control group, a letrozole-treated group (1 mg/kg/day, p.o.), a Reba-treated group (80 mg/kg/day, p.o.) and a group receiving niacinamide (NAM), a selective SIRT1 blocker (100 mg/kg/day, i.p.) in addition to Reba.
Key findings
Reba restored the normal morphological structure of the hippocampi with significant improvement in the rats' behaviors. Reba up-regulated SIRT1, a key regulator of numerous antioxidant and anti-inflammatory cascades, including Nrf2, SOD, and HO-1. The anti-inflammatory activity of SIRT-1 was revealed by the downregulation of NF-κB-p65, TNF-α, and NLRP3 inflammasome, as well as the upregulation of FoxO/wnt/β-catenin signaling. Furthermore, the anti-ferroptosis effects were demonstrated by the inhibition of total iron and ferrous levels as well as the upregulation of Gpx4 and SLC7A11 genes. Pre-treatment with NAM abolished Reba's neuroprotective effects.
Significance
Reba has a major neuroprotective role via activating SIRT1 and inhibiting related oxidative, neuroinflammatory, and ferroptosis pathways.
期刊介绍:
Life Sciences is an international journal publishing articles that emphasize the molecular, cellular, and functional basis of therapy. The journal emphasizes the understanding of mechanism that is relevant to all aspects of human disease and translation to patients. All articles are rigorously reviewed.
The Journal favors publication of full-length papers where modern scientific technologies are used to explain molecular, cellular and physiological mechanisms. Articles that merely report observations are rarely accepted. Recommendations from the Declaration of Helsinki or NIH guidelines for care and use of laboratory animals must be adhered to. Articles should be written at a level accessible to readers who are non-specialists in the topic of the article themselves, but who are interested in the research. The Journal welcomes reviews on topics of wide interest to investigators in the life sciences. We particularly encourage submission of brief, focused reviews containing high-quality artwork and require the use of mechanistic summary diagrams.